SecBot SecBot
SECBOTREPLAY Home › Report › BDMD

BDMD · Baird Medical received a Nasdaq deficiency notice for failing to…

Baird Medical Investment Holdings Limited · PRESS-RELEASE filed Nov 4, 2026 at 16:01 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Nov 4, 2026 at 16:01 ET

Baird Medical received a Nasdaq deficiency notice for failing to maintain the minimum $1.00 bid price for 30 consecutive business days. The company has a 180-day compliance period until May 3, 2027, to regain compliance, and its shares continue to trade uninterrupted. With a market cap of only $6M, the delisting risk is material if the bid price is not cured.

  • Nasdaq notified Baird Medical on November 2, 2026 of non-compliance with minimum $1.00 bid price rule (Listing Rule 5550(a)(2)).
  • Company has 180 calendar days, until May 3, 2027, to regain compliance by having a closing bid price of $1.00 or above for 10 consecutive business days.
  • If not cured, the company may be eligible for an additional 180-day grace period or face delisting.
  • Market cap is approximately $6M, making delisting a potentially existential risk.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access